These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
180 related articles for article (PubMed ID: 23393658)
1. Europe bets on drug discovery. Baker M Nature; 2013 Feb; 494(7435):20. PubMed ID: 23393658 [No Abstract] [Full Text] [Related]
2. Academia-pharma partnerships for novel drug discovery: essential or nice to have? Palmer M; Chaguturu R Expert Opin Drug Discov; 2017 Jun; 12(6):537-540. PubMed ID: 28394189 [No Abstract] [Full Text] [Related]
3. European lead factory opens for business. Mullard A Nat Rev Drug Discov; 2013 Mar; 12(3):173-5. PubMed ID: 23449292 [No Abstract] [Full Text] [Related]
4. Universities shun Europe's drug initiative. Gilbert N Nature; 2010 Jul; 466(7304):306-7. PubMed ID: 20631770 [No Abstract] [Full Text] [Related]
5. [Cohorts and registers: Which public/private partnerships to choose?]. Jouan-Flahault C; Landais P; Thomas R; Parker S; Genevaz D Presse Med; 2012 May; 41 Suppl 1():S15-9. PubMed ID: 22464892 [No Abstract] [Full Text] [Related]
6. The CNCCS, a benchmark Italian consortium for bioeconomy and an opportunity for the Istituto Superiore di Sanità . Ingrosso L; Rezza G; Pocchiari M; Garaci E Ann Ist Super Sanita; 2012; 48(2):115-6. PubMed ID: 22751551 [No Abstract] [Full Text] [Related]
7. The art of the alliance. Menzel GE; Xanthopoulos KG Nat Biotechnol; 2012 Apr; 30(4):313-5. PubMed ID: 22491275 [No Abstract] [Full Text] [Related]
8. Partners in discovery. Fuyuno I Nature; 2018 Mar; 555(7697):S60. PubMed ID: 29565400 [No Abstract] [Full Text] [Related]
9. Traditional drug-discovery model ripe for reform. Cressey D Nature; 2011 Mar; 471(7336):17-8. PubMed ID: 21368796 [No Abstract] [Full Text] [Related]
10. Drug development: Time for teamwork. May M Nature; 2014 May; 509(7498):S4-5. PubMed ID: 24784427 [No Abstract] [Full Text] [Related]
11. Competition: Unlikely partnerships. Savage N Nature; 2016 May; 533(7602):S56-8. PubMed ID: 27167391 [No Abstract] [Full Text] [Related]
12. Leveraging public private partnerships to innovate under challenging budget times. Portilla LM; Rohrbaugh ML Curr Top Med Chem; 2014; 14(3):326-9. PubMed ID: 24283971 [TBL] [Abstract][Full Text] [Related]
13. An audience with...Francis Collins. Interviewed by Asher Mullard. Collins F Nat Rev Drug Discov; 2011 Jan; 10(1):14. PubMed ID: 21151031 [No Abstract] [Full Text] [Related]
14. Towards a hit for every target. Rees S; Gribbon P; Birmingham K; Janzen WP; Pairaudeau G Nat Rev Drug Discov; 2016 Jan; 15(1):1-2. PubMed ID: 26585534 [TBL] [Abstract][Full Text] [Related]
15. Have microfluidics delivered for drug discovery? Chandrasekaran A; Abduljawad M; Moraes C Expert Opin Drug Discov; 2016 Aug; 11(8):745-8. PubMed ID: 27266956 [No Abstract] [Full Text] [Related]
16. Four disruptive strategies for removing drug discovery bottlenecks. Ekins S; Waller CL; Bradley MP; Clark AM; Williams AJ Drug Discov Today; 2013 Mar; 18(5-6):265-71. PubMed ID: 23098820 [TBL] [Abstract][Full Text] [Related]
17. Re-engineering drug discovery and development. FitzGerald GA LDI Issue Brief; 2011 Oct; 17(2):1-4. PubMed ID: 22049582 [TBL] [Abstract][Full Text] [Related]
18. The innovative medicines initiative: a case study for new ways of working in drug R&D. Laverty H; Goldman M Future Med Chem; 2014 Apr; 6(5):489-91. PubMed ID: 24649951 [No Abstract] [Full Text] [Related]
19. Dilemma over AI and drug patenting already under debate. King RD; Courtney P Nature; 2018 Aug; 560(7718):307. PubMed ID: 30108355 [No Abstract] [Full Text] [Related]
20. The innovative medicines initiative: a European response to the innovation challenge. Goldman M Clin Pharmacol Ther; 2012 Mar; 91(3):418-25. PubMed ID: 22318619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]